adalimumab,upadacitinib
abbvie
['upadacitinib', 'select,psa 1', 'psoriatic arthritis']
pos1541 long-term efficacy and safety of upadacitinib in patients with psoriatic arthritis: 3-year results from the phase 3 select-psa 1 study prof. iain mcinnes 10:30 cest location: poster view #eular2023
Versus Arthritis sponsors this collaboration with Birmingham, Glasgow,Newcastle & Oxford unis to hasten progress towards finding a cure for rheumatoid arthritis